BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dragasevic S, Stankovic B, Kotur N, Sokic-Milutinovic A, Milovanovic T, Lukic S, Milosavljevic T, Srzentic Drazilov S, Klaassen K, Pavlovic S, Popovic D. Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and Inflammation. Metab Syndr Relat Disord 2020;18:31-8. [PMID: 31750766 DOI: 10.1089/met.2019.0090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Tang H, Liang H, Bai X, Zhang H, Yang H, Wang H, Wang L, Qian J. Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China. Nutrients 2022;14:3040. [DOI: 10.3390/nu14153040] [Reference Citation Analysis]
2 Coleman MJ, Espino LM, Lebensohn H, Zimkute MV, Yaghooti N, Ling CL, Gross JM, Listwan N, Cano S, Garcia V, Lovato DM, Tigert SL, Jones DR, Gullapalli RR, Rakov NE, Torrazza Perez EG, Castillo EF. Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability. Metabolites 2022;12:431. [DOI: 10.3390/metabo12050431] [Reference Citation Analysis]
3 Deshpande D, Fuchs L, Klose CSN. Neuro-immune-metabolism: The tripod system of homeostasis. Immunol Lett 2021;240:77-97. [PMID: 34655659 DOI: 10.1016/j.imlet.2021.10.001] [Reference Citation Analysis]
4 Gholamalizadeh M, Akbari ME, Doaei S, Davoodi SH, Bahar B, Tabesh GA, Sadeghi H, Razavi Hashemi M, Kheyrani E, Rastgoo S, Hajipour A, Aslany Z, Mirfakhraie R, Mosavi Jarrahi A. The Association of Fat-Mass-and Obesity-Associated Gene Polymorphism (rs9939609) With Colorectal Cancer: A Case-Control Study. Front Oncol 2021;11:732515. [PMID: 34650918 DOI: 10.3389/fonc.2021.732515] [Reference Citation Analysis]
5 Bosch DE, Zen Y, Boukhar SA, Liu Y, Cheng L, Yeh MM. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Arch 2021. [PMID: 34414507 DOI: 10.1007/s00428-021-03183-6] [Reference Citation Analysis]
6 Maguire RL, House JS, Lloyd DT, Skinner HG, Allen TK, Raffi AM, Skaar DA, Park SS, McCullough LE, Kollins SH, Bilbo SD, Collier DN, Murphy SK, Fuemmeler BF, Gowdy KM, Hoyo C. Associations between maternal obesity, gestational cytokine levels and child obesity in the NEST cohort. Pediatr Obes 2021;16:e12763. [PMID: 33381912 DOI: 10.1111/ijpo.12763] [Reference Citation Analysis]
7 Her JY, Lee Y, Kim SJ, Heo G, Choo J, Kim Y, Howe C, Rhee SH, Yu HS, Chung HY, Pothoulakis C, Im E. Blockage of protease-activated receptor 2 exacerbates inflammation in high-fat environment partly through autophagy inhibition. Am J Physiol Gastrointest Liver Physiol 2021;320:G30-42. [PMID: 33146548 DOI: 10.1152/ajpgi.00203.2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Xu X, Zhang L, Zhao Y, Xu B, Qin W, Yan Y, Yin B, Xi C, Ma L. Anti‑inflammatory mechanism of berberine on lipopolysaccharide‑induced IEC‑18 models based on comparative transcriptomics. Mol Med Rep 2020;22:5163-80. [PMID: 33174609 DOI: 10.3892/mmr.2020.11602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Chen L, Xiao WJ, Yan QX, Gong ZH, Zhang S, Zeng L, Yang M, Zhou YH. Protective effects of L-theanine on rats with dextran sulfate sodium-induced inflammatory bowel disease. Arch Pharm Res 2020;43:821-62. [PMID: 32720164 DOI: 10.1007/s12272-020-01248-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]